The acute and short-time effect of supplementation with the combination of n-3 fatty acids and acetylsalicylic acid on platelet function and plasma lipids

被引:19
作者
Svaneborg, N
Kristensen, SD
Hansen, LM
Büllow, I
Husted, SE
Schmidt, EB [1 ]
机构
[1] Hjorring Hosp, Dept Med, DK-9800 Hjorring, Denmark
[2] Aalborg Hosp, Dept Clin Chem, Aalborg, Denmark
[3] Skejby Hosp, Univ Dept Cardiol, Aarhus, Denmark
[4] Alborg Hosp, Dept Med, Aalborg, Denmark
[5] Cty Hosp Aarhus, Univ Dept Med & Cardiol, Aarhus, Denmark
关键词
n-3 polyunsaturated fatty acids; fish oil; acetylsalicylic acid; lipids; platelet aggregation; bleeding time;
D O I
10.1016/S0049-3848(02)00010-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Antiplatelet therapy with acetylsalicylic acid (ASA) is commonly used to reduce the risk of cardio- and cerebrovascular events. Fish consumption has been inversely related to coronary disease, which has been partly attributed to an inhibitory effect of n - 3 polyunsaturated fatty acids (n - 3 PLEA) on platelet production of tromboxane A(2). In this study, we investigated the acute and short-time effect of supplementation with n - 3 PUFA and intravenous ASA on platelet function, platelet fatty acid composition and plasma lipids. Eighteen healthy men were randomly allocated to a daily intake of 10 g n - 3 PUFA or placebo. After this supplement (14 h and 14 days), blood was sampled before and after intravenous injection of 100 mg ASA. n - 3 PUFA given for 14 days caused a minor inhibition of platelet reactivity but negligible compared to 100 mg ASA. No additive effect of n - 3 PUFA and ASA Could be demonstrated. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:311 / 316
页数:6
相关论文
共 28 条
[1]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[2]  
BURR ML, 1989, LANCET, V2, P757
[3]   ASPIRIN-INDUCED DECLINE IN PROSTACYCLIN PRODUCTION IN PATIENTS WITH CORONARY-ARTERY DISEASE IS DUE TO DECREASED ENDOPEROXIDE SHIFT - ANALYSIS OF THE EFFECTS OF A COMBINATION OF ASPIRIN AND N-3 FATTY-ACIDS ON THE EICOSANOID PROFILE [J].
FORCE, T ;
MILANI, R ;
HIBBERD, P ;
LORENZ, R ;
UEDELHOVEN, W ;
LEAF, A ;
WEBER, P .
CIRCULATION, 1991, 84 (06) :2286-2293
[4]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[5]  
GOODNIGHT SH, 1981, BLOOD, V58, P880
[6]   THE COMBINED EFFECTS OF N-3 FATTY-ACIDS AND ASPIRIN ON HEMOSTATIC PARAMETERS IN MAN [J].
HARRIS, WS ;
SILVEIRA, S ;
DUJOVNE, CA .
THROMBOSIS RESEARCH, 1990, 57 (04) :517-526
[7]  
HUSTED SE, 1992, THROMB HAEMOSTASIS, V68, P226
[8]  
Kristensen S D, 1991, Platelets, V2, P11, DOI 10.3109/09537109109005497
[9]  
KRISTENSEN SD, 1993, BRIT HEART J, V70, P212
[10]  
KRISTENSEN SD, 1992, DAN MED BULL, V39, P110